Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

NCT04870034 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Issues recruiting

Conditions

Colorectal Carcinoma
Lung Adenocarcinoma
Malignant Solid Neoplasm
Pancreatic Carcinoma

Interventions

DRUG: Binimetinib
DRUG: Palbociclib
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

Roswell Park Cancer Institute